SARS-CoV-2 Displays a Suboptimal Codon Usage Bias for Efficient Translation in Human Cells Diverted by Hijacking the tRNA Epitranscriptome

被引:0
|
作者
Eldin, Patrick [1 ]
David, Alexandre [2 ,3 ]
Hirtz, Christophe [3 ]
Battini, Jean-Luc [1 ]
Briant, Laurence [1 ]
机构
[1] Univ Montpellier, Inst Rech Infectiol Montpellier IRIM, CNRS, UMR 9004, 1919 Route Mende, F-34293 Montpellier, France
[2] INSERM, U1191, Inst Genom Fonct IGF, 141 Rue Cardonille, F-34000 Montpellier, France
[3] Univ Montpellier, Inst Regenerat Med & Biotherapy IRMB Plateforme Pr, Inst Neurosci Montpellier INM, CHU Montpellier,INSERM,CNRS, 298 Rue Truel, F-34090 Montpellier, France
关键词
SARS-CoV-2; codon usage; tRNA; epitranscriptome; translation; POLYMERASE-III TRANSCRIPTION; MESSENGER-RNA; ADAPTATION INDEX; CLUSTER-ANALYSIS; EFFECTIVE NUMBER; GENES; PROTEIN; GENOME; ABUNDANCE; CANCER;
D O I
10.3390/ijms252111614
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Codon bias analysis of SARS-CoV-2 reveals suboptimal adaptation for translation in human cells it infects. The detailed examination of the codons preferentially used by SARS-CoV-2 shows a strong preference for Lys(AAA), Gln(CAA), Glu(GAA), and Arg(AGA), which are infrequently used in human genes. In the absence of an adapted tRNA pool, efficient decoding of these codons requires a 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)) modification at the U-34 wobble position of the corresponding tRNAs (tLys(UUU); tGln(UUG); tGlu(UUC); tArg(UCU)). The optimal translation of SARS-CoV-2 open reading frames (ORFs) may therefore require several adjustments to the host's translation machinery, enabling the highly biased viral genome to achieve a more favorable "Ready-to-Translate" state in human cells. Experimental approaches based on LC-MS/MS quantification of tRNA modifications and on alteration of enzymatic tRNA modification pathways provide strong evidence to support the hypothesis that SARS-CoV-2 induces U-34 tRNA modifications and relies on these modifications for its lifecycle. The conclusions emphasize the need for future studies on the evolution of SARS-CoV-2 codon bias and its ability to alter the host tRNA pool through the manipulation of RNA modifications.
引用
收藏
页数:26
相关论文
共 50 条
  • [41] Bat coronaviruses related to SARS-CoV-2 and infectious for human cells
    Temmam, Sarah
    Vongphayloth, Khamsing
    Baquero, Eduard
    Munier, Sandie
    Bonomi, Massimiliano
    Regnault, Beatrice
    Douangboubpha, Bounsavane
    Karami, Yasaman
    Chretien, Delphine
    Sanamxay, Daosavanh
    Xayaphet, Vilakhan
    Paphaphanh, Phetphoumin
    Lacoste, Vincent
    Somlor, Somphavanh
    Lakeomany, Khaithong
    Phommavanh, Nothasin
    Perot, Philippe
    Dehan, Oceane
    Amara, Faustine
    Donati, Flora
    Bigot, Thomas
    Nilges, Michael
    Rey, Felix A.
    van der Werf, Sylvie
    Brey, Paul T.
    Eloit, Marc
    NATURE, 2022, 604 (7905) : 330 - +
  • [42] Human ACE2 Genetic Polymorphism Affecting SARS-CoV and SARS-CoV-2 Entry into Cells
    Hattori, Takanari
    Saito, Takeshi
    Okuya, Kosuke
    Takahashi, Yuji
    Miyamoto, Hiroko
    Kajihara, Masahiro
    Igarashi, Manabu
    Takadaa, Ayato
    MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [43] Delivery of Recombinant SARS-CoV-2 Envelope Protein into Human Cells
    Capone, Ricardo
    Hutchison, James M.
    Luu, Dustin D.
    Hadziselimovic, Arina
    Van Horn, Wade D.
    Sanders, Charles R.
    PROTEIN SCIENCE, 2021, 30 : 62 - 62
  • [44] The SARS-CoV-2 RNA–protein interactome in infected human cells
    Nora Schmidt
    Caleb A. Lareau
    Hasmik Keshishian
    Sabina Ganskih
    Cornelius Schneider
    Thomas Hennig
    Randy Melanson
    Simone Werner
    Yuanjie Wei
    Matthias Zimmer
    Jens Ade
    Luisa Kirschner
    Sebastian Zielinski
    Lars Dölken
    Eric S. Lander
    Neva Caliskan
    Utz Fischer
    Jörg Vogel
    Steven A. Carr
    Jochen Bodem
    Mathias Munschauer
    Nature Microbiology, 2021, 6 : 339 - 353
  • [45] Bat coronaviruses related to SARS-CoV-2 and infectious for human cells
    Sarah Temmam
    Khamsing Vongphayloth
    Eduard Baquero
    Sandie Munier
    Massimiliano Bonomi
    Béatrice Regnault
    Bounsavane Douangboubpha
    Yasaman Karami
    Delphine Chrétien
    Daosavanh Sanamxay
    Vilakhan Xayaphet
    Phetphoumin Paphaphanh
    Vincent Lacoste
    Somphavanh Somlor
    Khaithong Lakeomany
    Nothasin Phommavanh
    Philippe Pérot
    Océane Dehan
    Faustine Amara
    Flora Donati
    Thomas Bigot
    Michael Nilges
    Félix A. Rey
    Sylvie van der Werf
    Paul T. Brey
    Marc Eloit
    Nature, 2022, 604 : 330 - 336
  • [46] Infecting human hematopoietic stem and progenitor cells with SARS-CoV-2
    Encabo, Hector Huerga
    Ulferts, Rachel
    Sharma, Aneesh
    Beale, Rupert
    Bonnet, Dominique
    STAR PROTOCOLS, 2021, 2 (04):
  • [47] Transcriptional landscape of human neuroblastoma cells in response to SARS-CoV-2
    Yang, Rui-Cheng
    Huang, Kun
    Zhang, Hui-Peng
    Li, Liang
    Tan, Chen
    Chen, Huan-Chun
    Jin, Mei-Lin
    Wang, Xiang-Ru
    BMC NEUROSCIENCE, 2022, 23 (01)
  • [48] Neuropathogenesis of SARS-CoV-2 in human neuronal, microglial and glial cells
    Kumar, Narendra
    Santhoshkumar, Rashmi
    Agrawal, Ragini
    Singh, Amit
    Kalyan, Vijayalakshmi
    Desai, Anita
    Ravi, Vasanthapuram
    Venkataswamy, Manjunatha M.
    ARCHIVES OF MICROBIOLOGY, 2024, 206 (08)
  • [49] Fluvastatin mitigates SARS-CoV-2 infection in human lung cells
    Zapatero-Belinchon, Francisco J.
    Moeller, Rebecca
    Lasswitz, Lisa
    van Ham, Marco
    Becker, Miriam
    Brogden, Graham
    Rosendal, Ebba
    Bi, Wenjie
    Carriqui-Madronal, Belen
    Islam, Koushikul
    Lenman, Annasara
    Gunesch, Antonia P.
    Kirui, Jared
    Pietschmann, Thomas
    Overby, Anna K.
    Jansch, Lothar
    Gerold, Gisa
    ISCIENCE, 2021, 24 (12)
  • [50] Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2
    Zeng, Weijie
    Xing, Fan
    Ji, Yanxi
    Yang, Sidi
    Xu, Tiefeng
    Huang, Siyao
    Li, Chunmei
    Wu, Junyu
    Cao, Liu
    Guo, Deyin
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12